BRIEF published on 02/12/2026 at 18:05, 5 months 23 days ago THX Pharma annonce un webinaire sur son accord stratégique avec Biocodex Webinaire Accord Stratégique Batten-1 THX Pharma Biocodex
BRIEF published on 02/12/2026 at 18:05, 5 months 23 days ago THX Pharma et Biocodex concluent un accord stratégique majeur Webinaire Accord Stratégique THX Pharma Médicaments Neurologiques Biocodex
BRIEF published on 02/12/2026 at 18:05, 5 months 23 days ago THX Pharma Announces Webinar on Strategic Agreement with Biocodex Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 5 months 23 days ago THX Pharma organise un webinaire pour commenter son accord stratégique avec Biocodex THX Pharma annonce un webinaire pour discuter de son accord avec Biocodex portant sur le développement de traitements pour les maladies neurologiques rares Webinaire Accord Stratégique Maladies Neurologiques Rares THX Pharma Biocodex
PRESS RELEASE published on 02/12/2026 at 18:00, 5 months 23 days ago THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 5 months 25 days ago Accord Stratégique entre THX Pharma et Biocodex pour trois Maladies Rares Maladies Rares Accord De Licence THX Pharma Biocodex Batten-1 Et TX01
BRIEF published on 02/10/2026 at 18:05, 5 months 25 days ago Strategic Licensing Agreement for Rare Disease Treatments Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 5 months 25 days ago Accord de licence stratégique pour les traitements des maladies rares Accord Stratégique Maladies Rares Accord De Licence THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 5 months 25 days ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
PRESS RELEASE published on 02/10/2026 at 18:00, 5 months 25 days ago THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties Batten-1 Licenses TX01 THX Pharma Biocodex
Published on 08/07/2026 at 23:15, 12 hours 42 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 12 hours 57 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 13 hours 27 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 13 hours 42 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/07/2026 at 23:21, 12 hours 36 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 16 hours 27 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 16 hours 42 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 17 hours 47 minutes ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 17 hours 57 minutes ago E-PANGO: Composition du capital au 31 juillet 2026
Published on 08/07/2026 at 18:54, 17 hours 3 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 17 hours 3 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 17 hours 17 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 17 hours 17 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 17 hours 57 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
